StockDuty ← Dashboard Aug 13, 2026 11:48 PM ET
CatalystFDA/Bio

BELITE BIO OUTLINES FEBRUARY 12, 2027 PDUFA DATE FOR TINLAREBANT IN STARGARDT DISEASE FOLLOWING FDA PRIORITY REVIEW ACCEPTANCE - SEEKINGALPHA

PDUFA date and priority review signal regulatory catalyst for tinlarebant.

What changed
Why it matters
PDUFA date and priority review signal regulatory catalyst for tinlarebant.
Sources
seekingalpha
Related signals
PHASE 1 OF INDIA - US TRADE PACT HINGES ON SECTION 301 PROBE , OFFICIAL SAYS →PITNEY BOWES OUTLINES PHASE 2 STRATEGIC REVIEW WHILE PUSHING NEAREST DEBT MATURITY TO MARCH 2029 - SEEKINGALPHA →UNICYCIVE PLUMMETS FOLLOWING SECOND CRL FOR OLC FOR HYPERPHOSPHATEMIA - SEEKINGALPHA →